HomeNewsTrendsFeaturesLuxury fashion brands bet on anti-virus fabrics to revive fortunes amid COVID-19

Luxury fashion brands bet on anti-virus fabrics to revive fortunes amid COVID-19

Brands such as Armani and Diesel are collaborating with companies with proprietary anti-viral technology to create luxury fabrics. India has also thrown its hat in the ring.

October 17, 2020 / 07:45 IST
Story continues below Advertisement

Can your clothes protect you from something as serious as COVID-19 at the very extreme, or at least from other germs and viruses at the very least?

The luxury industry has been abuzz with the news that a leading Italian fabric manufacturer, Albini Group, has developed an anti-viral fabric that was being snapped up by fashion industry behemoths.

Story continues below Advertisement

How big? Think Kering (Gucci, Alexander McQueen, Saint Laurent, et al), Armani, Ermenegildo Zegna and Prada, to name a few. Named ViroFormula Fabric, it is the result of an innovative collaboration between Albini and Swiss textile innovation firm, HeiQ.

The process involves applying chemicals to textiles during the production process. The efficacy tests, Albini tells us in a statement, was conducted with a virus called 229E, said to be similar to SAR-COV-2 (WHO has strictly banned the use of the SAR-COV-2 virus, which causes COVID). They proved that the anti-virus textile can destroy the virus with a few minutes of contact.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show